Movement Disorders and Oculomotor Abnormalities in Whipple’s Disease: An Updated Systematic Review
Tremor and Other Hyperkinetic Movements · 11.11.2025 · 15 · 57
DOI: 10.5334/tohm.1075 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Tremor and Other Hyperkinetic Movements, online erschienen am 11.11.2025. Verfasst von Errikos Maslias und 4 weiteren Autor:innen. Beteiligte Einrichtung: Service of Neurology, Department of Clinical Neurosciences, Lausanne University Hospital (CHUV) and University of Lausanne, Lausanne, Switzerland. Hauptthemen laut MEDLINE: Movement Disorders, Ocular Motility Disorders, Whipple Disease. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Whipple’s disease (WhD) is a rare multisystemic infection caused by Tropheryma whipplei, with central nervous system (CNS) involvement seen in up to 50% of cases. Neurological symptoms may precede systemic features or occur in isolation. Movement disorders (MDs) and oculomotor abnormalities, especially oculomasticatory myorhythmia (OMM) and oculofacioskeletal myorhythmia (OFSM), are of a high diagnostic importance but remain underrecognized. This systematic review aims to update our understanding of MDs in CNS-WhD, building on a 2018 review.
Methods
A systematic search of MEDLINE, EMBASE, and Cochrane Library was performed for English-language human studies published between 01/2017-05/2025. Search terms targeted WhD and MDs. Titles, abstracts and full-text were screened in Rayyan.ai, by two independent reviewers.
Results
We added 19 articles (22 new cases) to the 100 articles (146 cases) from the previous report, making up a total of 168 CNS-WhD patients with MDs or oculomotor abnormalities. Supranuclear gaze palsy (SGP) was the most common sign (58%), followed by myorhythmia and ataxia (40% each). Pathognomonic OMM/OFSM were identified in 25% of cases, higher than previously reported. MRI showed abnormalities in 87% of cases, and brain tissue PAS staining had the highest diagnostic yield, although mostly performed post-mortem. Treatment with ceftriaxone followed by Trimethoprim-Sulfamethoxazole remained common, though doxycycline–hydroxychloroquine use has increased. MDs improved in 53% of cases.
Conclusion
Oculomotor abnormalities and MDs, especially SGP and OMM/OFSM/other myorhythmia, are key diagnostic clues in CNS-WhD, even in the absence of systemic symptoms. Greater diagnostic awareness is essential to improve outcomes of this life-threatening, but treatable, condition.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Service of Neurology, Department of Clinical Neurosciences, Lausanne University Hospital (CHUV) and University of Lausanne, Lausanne, Switzerland.
- University of Lausanne, Lausanne, Switzerland.
- German Cancer Consortium (DKTK), Partner Site Berlin, German Cancer Research Center (DKFZ), Heidelberg, Germany.
- Department of Neuropathology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany.
ORCID-Profile: Errikos Maslias, Philip Euskirchen, Karin Diserens, Julien F Bally
Zitieren
APA
Maslias, E., Anker, R., Euskirchen, P., Diserens, K., & Bally, J. F. (2025). Movement Disorders and Oculomotor Abnormalities in Whipple’s Disease: An Updated Systematic Review. Tremor and Other Hyperkinetic Movements, 15, 57. https://doi.org/10.5334/tohm.1075
Vancouver
Maslias E, Anker R, Euskirchen P, Diserens K, Bally JF. Movement Disorders and Oculomotor Abnormalities in Whipple’s Disease: An Updated Systematic Review. Tremor and Other Hyperkinetic Movements. 2025;15:57. doi:10.5334/tohm.1075
BibTeX
@article{Maslias2025,
author = {Maslias, Errikos and Anker, Ruben and Euskirchen, Philip and Diserens, Karin and Bally, Julien F},
title = {Movement Disorders and Oculomotor Abnormalities in Whipple’s Disease: An Updated Systematic Review},
journal = {Tremor and Other Hyperkinetic Movements},
year = {2025},
volume = {15},
pages = {57},
doi = {10.5334/tohm.1075}
}
EUVIMED